Success Stories: A Research Scientist III in the Field of Bioanalytical Chemistry from China Achieved NIW Approval Within 6 Months, No RFE
Client’s Testimonial:
“Thank you very much, you guys did a great job.”
On March 31st, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist III in the Field of Bioanalytical Chemistry (Approval Notice).
General Field: Bioanalytical Chemistry
Position at the Time of Case Filing: Research Scientist III
Country of Origin: China
State of Residence at the Time of Filing: Ohio
Approval Notice Date: March 31st, 2021
Processing Time: 6 months, 19 days
Case Summary:
A research scientist III in the field of bioanalytical chemistry contacted North America Immigration Law Group to assist him in filing an EB-2 NIW (National Interest Waiver) petition on his behalf. Before agreeing to take his case, we evaluated his professional and academic background as a part of our legal service. After a considerate assessment, we counter-signed the client-attorney contract and started building a strong case for him by adding the following required details in our petition packet:
- Firstly, we highlighted our client’s proposed research on utilizing liquid chromatography and mass spectrometry to analyze messenger RNA drugs in order to reduce drug impurities and enhance drug efficacy. His research work is of great importance because it improves the development, overall efficacy, and safety of pharmaceuticals.
- We also noted his 4 peer-reviewed journal articles, including articles in top-ranked and highly exclusive journals which accumulated 178 citations. His publications have been the most cited in the field, symbolizing both the originality and significance of his ways and outcomes. These facts prove that he holds a central role in bioanalytical chemistry research as he has provided new knowledge into the analysis of RNA modifications, highlighting his capacity to enhance the efficacy of RNA-based pharmaceuticals.
“Through his development of RNA modification analysis software, [client] has aided drug development, and in turn, contributed to the sale of more accurate and effective drugs for the millions of Americans that rely on them daily. It is clear that his work has benefitted the United States and will continue to do so in the future.”
His EB-2 NIW was approved within 6 months, without any further request for evidence, setting it as another example of our law firm’s diligence. We truly thank our client for associating with us and we wish him well as he continues to advance the field of bioanalytical chemistry with his extensive research.

